cGxP.wire https://validator.w3.org/feed/docs/rss2.html Castle Biosciences Advances Barrett’s Risk Testing With TissueCypher Invivyd Reports Positive Phase 3 LIBERTY Data for VYD2311 PolarityBio to Present Phase 3 SkinTE Data at SAWC Fall 2026 uniQure Reports 48-Month AMT-130 Data in Huntington’s Disease Cellectar Reports Iopofosine I 131 Data in BTKi-Refractory Waldenström Macroglobulinemia Medicus Pharma Submits Optimized Teverelix Registrational Protocol to FDA Cartesian Reports Durable Descartes-08 Retreatment Data in MG Cognition Therapeutics Schedules FDA Type C Meeting for Zervimesine JCR Gains Japan Orphan Drug Designation for Givinostat Acadia Gains U.S. Patent Allowance for Trofinetide Dosing Verastem Reports Two-Year RAMP 201 Data in LGSOC Eccogene Receives $50M Milestone After Elecoglipron Phase 3 Start AstraZeneca Invests $2 Billion in Summit Therapeutics Kither Biotech Doses First Patients in KIT2014 COPD Trial Cyprumed Oral Delivery Technology Enters Clinical Stage With MSD TransCode Advances TTX-MC138 in Phase 1a Cancer Trial Lakewood-Amedex Reports Positive Nu-3 Antimicrobial Data SetPoint Medical Expands RA Neuroimmune Therapy Access AbbVie Wins FDA Approval for JUVMO in Parkinson’s Disease Caspian Unveils KO-7246 Preclinical Diabetes Data at EASD Nektar Advances Rezpegaldesleukin at EADV Congress 2026 Mirum Advances Brelovitug in Phase 3 HDV Trial Truth Initiative Urges Stronger FDA Review of New Tobacco BRC Therapeutics Advances Botanical Drug Development Mirum Advances Brelovitug in Phase 3 Hepatitis Delta Trial Lupin Receives FDA Approval for Apixaban Oral Suspension Eli Lilly Wins FDA Approval for Once-Weekly Onswik Amlan International Advances Dairy Animal Health at Expo XtalPi Advances KQTD-126 Into FDA IND Review Mirum Pharmaceuticals Wins FDA Approval for ATEBRIOZ HUTCHMED and AstraZeneca Submit US NDA for ORPATHYS Plus TAGRISSO REGENXBIO Reports Three-Year Data for Surabgene in Retinopathy Immuneering Presents Atebimetinib Pancreatic Cancer Data at AACR Castle Biosciences Study Supports Molecular Guidance in AD Henlius Partners With Amberstone on Next-Gen TCEs CervoMed Advances Neflamapimod With New Tablet and FDA Dose Flexibility Pfizer to Present 45 Oncology Abstracts at ESMO 2026 AN2 Therapeutics Extends GSK Tuberculosis Research Collaboration Leads Biolabs Gains Japan Orphan Drug Designation for Opamtistomig Codexis Partners With siRNA Innovator on Stereo-Defined Synthesis Atavistik Bio Partners With Roche on Allosteric Drug Discovery Eton Launches U.S. Commercial Availability of IMPAVIDO Glycomine Gains FDA Breakthrough Status for GLM101 Tiziana Doses First Participants in ALS Foralumab Trial Boehringer Ingelheim and WHO Foundation Expand Obesity Care Sagimet to Present 52-Week Denifanstat Data at KOL Event WuXi Biologics Passes FDA GMP Inspection at Wuxi Site 4basebio and TriLink Advance Phase I Cell Therapy Program Clywedog Therapeutics Reports Phase 1b Balomenib Results Moleculin Reports Cardiac Safety Data for Annamycin